跳至主要内容
临床试验/NCT01844037
NCT01844037终止2 期

Renal Denervation Using the OneShot Ablation System

Medtronic Endovascular1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
51
试验地点
1
主要终点
Change in office systolic blood pressure (SBP) from baseline to 6 months

研究概览

简要总结

This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is an acceptable candidate for renal denervation based upon the Instructions for Use.
  • Patient is ≥ 18 years old.
  • Patient provided written informed consent.

排除标准

  • Patients who are pregnant, nursing, or planning to become pregnant.
  • Patients who have only one functioning kidney.
  • Allergy to contrast or known hypersensitivity to device materials
  • Patients with renal arteries < 4 mm in diameter.
  • Patients whose life expectancy is less than the planned period of study involvement.

结局指标

主要结局

Change in office systolic blood pressure (SBP) from baseline to 6 months

时间窗: 6 months

次要结局

  • Change in office diastolic blood pressure (DBP)(6 and 12 months post procedure)
  • Change in office SBP(6 and 12 months post procedure)
  • Acute procedural safety, defined as freedom from renal artery dissection or perforation requiring intervention.(One Week)

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

OneShot Renal Denervation Registry | 临床试验